Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 May 2022 | Story Rulanzen Martin | Photo Supplied
Dr Sello Thinane
Dr Jonas Thinane graduated with a PhD from the University of South Africa.

Dr Jonas Thinane, who recently obtained his PhD in Theology from the University of South Africa (Unisa), has been working in the Department of Hebrew since his first year as a Theology student; he is currently employed as departmental administrator in the department. 

It was his diligence and comments that convinced Prof Cynthia Miller-Naude to offer him employment as student assistant in the department.  His work involves overseeing the administration of three entwined units within the department.  “I am really proud of all that he has accomplished since then, seizing every opportunity available for learning and growing, without allowing obstacles to block his path,” said Prof Miller-Naude. 

His PhD focused on Human rights abuse by some self-styled spiritual leaders within the ‘Nyaope religion’ in South Africa and was supervised by Prof MS Kgatle from the Department of Christian Spirituality, Church History and Missiology at Unisa. 

An avid academic and researcher 

Apart from the research he undertook to complete his PhD in less than two years, he published nine accredited articles and a chapter in a book between 2021 and 2022. “I currently have six articles undergoing peer review and am working on more to publish in local and international journals this year,” says Dr Thinane. 

Dr Thinane’s research specialisation lies within Missiology, where he has introduced new knowledge to the subject matter through extensive writing on concepts of missio hominum (mission of human beings) in relation to the broader setting of the Missio Dei (Mission of God). “Beyond this, some of my published articles cover broad yet relevant topics such as COVID-19 and vaccine challenges in South Africa, the question of mandatory vaccination from a religious perspective, the ANC step-aside rule in conflict with Thuma Mina objectives, and many other topics relevant to our current challenges in South Africa,” Dr Thinane says. 

“I am sure that he will make a great contribution to academia for the benefit of society in the future,” says Prof Miller-Naude. 

Support and motivation from department 

Dr Thinane is very appreciative of the support he received from the department throughout his PhD journey. 
This is indeed a great achievement within the scope of the UFS’ encouragement for publication on subjects that greatly contribute to the cognition and advancement of our society.
Dr Thinane graduation
From the left: Dr KJ Padi (UFS Practical and Missional Theology), Dr A Motsei (UFS African Languages), Dr JS Thinane (Department of Hebrew),
Dr M Choane (UFS Political Studies and Governance), Prof MS Kgatle (UNISA Department of Christian Spirituality, Church History and Missiology),
Dr ME Maibi (UFS alumnus). (Photo: Supplied)

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept